Should we change our prophylactic antimicrobial regimen for prostate biopsy?

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1181-1183

  Pearle, Margaret S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL PRACTICE; COLIFORM BACTERIUM; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EDITORIAL; ESCHERICHIA COLI; HEALTH CARE COST; HUMAN; INTESTINE FLORA; LENGTH OF STAY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; URINE CULTURE;

ANTIBIOTIC PROPHYLAXIS; BIOPSY; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE; RECTUM; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79952705180     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2011.01.046     Document Type: Editorial

References (11)

1. Wolf JS Jr, Bennett CJ, Dmochowski RR et al: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008; 179: 1379.
2. Feliciano J, Teper E, Ferrandino M et al: The incidence of fluoroquinolone resistant infections after prostate biopsy - are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952.
3. Binsaleh S, Al-Assiri M, Aronson S et al: Septic shock after transrectal ultrasound guided prostate biopsy. Is ciprofloxacin prophylaxis always protecting? Can J Urol 2004; 11: 2352.
4. Loeb S, Carter HB, Berndt S et al: How safe is prostate biopsy? Rate of complications requiring hospitalization following prostate biopsy in SEER-Medicare. J Urol, suppl., 2010; 183: e815, abstract 2096.
5. Nam R, Klotz L, Loblaw A et al: Rising hospital admission rates for urologic complications after transrectal ultrasound-guided prostate biopsy. J Urol, suppl., 2010; 183: e815, abstract 2097.
6. Batura D, Rao GG and Nielsen PB: Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010; 106: 1017.
7. Cermak A, Mareckova N and Pacik D: Infectious complications of prostate biopsy: the changes in antibiotics resistance patterns - the review of 5-year period. J Urol, suppl., 2010; 183: e817, abstract 2101.
8. Lange D, Zappavigna C, Hamidizadeh R et al: Bacterial sepsis after prostate biopsy - a new perspective. Urology 2009; 74: 1200.
9. Jung SI, Park JB, Hwang EC et al: Clinical aspect of post TRUS biopsy infection caused by quinolone-resistent bacteria. J Urol, suppl., 2010; 183: e315, abstract 808.
10. Shigemura K, Yasufuku T, Matsumoto M et al: Can penicillin including beta-lactamase inhibitor overcome febrile complications after transrectal prostate biopsy? J Urol, suppl., 2010; 183: e316, abstract 809.
11. Uddin MM, Ho HSS, Ng LG et al: Transrectal prostate biopsy sepsis: trends in its bacteriology and antibiotic prophylaxis in a single center over 8 years. J Urol, suppl., 2010; 183: e315, abstract 807.